PROGRAMME
Please see programme below. Subject to change.
Register now for SAVVY Express at the Science Media Centre to sharpen your media skills and science communication. Click here for more information.
The Summit will feature talks from the Te-Niwha funded research:
| PROJECT TITLE | RESEARCH LEADERS |
| Landscape Mapping Infectious Diseases by research
investment, burden of disease and Research Capability | Dr Seini Taufa, Amio Matenga Ikihele |
| COVID-19 Equity Response Synthesis (for proactive
evaluation and gap analysis | Dr Seini Taufa, Amio Matenga Ikihele |
| Post-Pandemic Lifting of Immunisation by Proactive Evaluation | Riki Nia Nia, Shaun Akroyd |
| Rongoā Māori Bioactivity & Efficacy potential
as a novel Infectious Diseases Treatments | Dr Jonni Koia, Dr Isabel Moller |
| Likely future pandemic agents and scenarios | Dist Prof. Nigel French |
| Preventing recurrent admissions for preschool wheeze respiratory infections | Prof Cameron Grant, Marisa van Arragon |
| The perceptions of risk and management of
infectious disease among Pacific Youth: To examine the role of social networks
and social media for effective (and culturally relevant) communications. | Sir Collin Tukuitonga, Prof Judith McCool |
PRIROITY THEME RESEARCH PROJECTS
| PRIORITY THEME | PROJECT TITLE | RESEARCH LEADERS |
| Diagnostics | Rapid point of use testing for infectious diseases in the community | Dr Craig Billington, Dr Rachel Fleming |
| Diagnostics | Development of non-invasive “liquid biopsy” methods
for infectious disease using microbial cell-free DNA | Dr Amy Scott-Thomas, Prof Stephen Chambers |
| Diagnostics | Genomics-informed detection, surveillance and capacity building to prepare Aotearoa for the existential threat of highly pathogenic avian influenza virus | Prof Jemma Geoghegan, Dr David Winter |
| Diagnostics | Mahi Tahi: Decreasing transmission and improving
diagnosis of Tuberculosis to reduce health inequities | A/Prof Jo Kirman |
| Prevention | A randomised controlled trial of the immunogenicity and reactogenicity of subcutaneous vs intramuscular administration of COVID 19 vaccination in community pharmacies in Aotearoa New Zealand | Dr Gabby Shortt, Prof Richard Beasley |
| Prevention | Anational burden of disease analysis of water borne disease from communitydrinking water infrastructure | A/Prof Tim Chambers, Connor Redmile |
| Prevention | Hurtsless, lasts longer: Applying Māori and Pacific patient-centered models to implement subcutaneous infusions of high dose penicillin to prevent RHD | Dr Julie Bennett, Dr Anneka Anderson |
| Prevention | Improving models for pandemic preparedness and
response: modelling differences in infectious disease dynamics and impact by
ethnicity. | Dr Samik Datta, Andrew Sporle, Prof Michael Plank |
| Surveillance | Making use of wastewater from aircraft and individual buildings for better infectious disease epidemiology and response | Dr Brent Gilpin |
| Surveillance | Addressing gaps in the surveillance and response to influenza like illness: Community pharmacy based feasibility study | Kyley Kerse, Prof Alex Semprini |
| Surveillance | Community based surveillance of severe bacterial
pathogens to guide prevention and control | Dr Xiaoyun (Una) Ren |
| Surveillance | Understanding the surveillance barriers and the health burden of emerging disease threats for Aotearoa: Vibrio as a case study | Dr Lucia Rivas, Maria Hepi |
| Surveillance | Improving the safety and effectiveness of leprosy
treatment in Kiribati through enhanced surveillance of drug resistance and
detection of factors predisposing to dapsone reactions | Dr Nick Douglas, Prof Stephen Chambers |
| Surveillance | Infectious
disease surveillance in Aotearoa | Prof Michael Baker |
| Therapeutics | Promoting equitable access to effective treatment for Staphylococcus aureus bacteraemiain Aotearoa: probenecid boosted oral antibiotic dosing in the SNAP study (PR OSNAP) | Dr Max Bloomfield, Dr Genevieve Walls |
| Therapeutics | Broadspectrum antiviral development of PI3K inhibitor compounds | Dr Natalie Netzler |
| Therapeutics | Addressing inequity in antibiotic use strengthening antimicrobial stewardship throughout Aotearoa to improve the health of New Zealanders | Dr Stephen Ritchie, Dr Karen Wright |
| Therapeutics | REMAP-CAP– identifying novel therapeutics for severe seasonal influenza while preparing for the next global influenza pandemic | Dr Colin McArthur, Dr Thomas Hills, Dr Anthony Jordan |
| Te Ao Maaori | Whiitiki Whakatika | Huirama Matatahi, Dr Rangimarie Mahuta |
WHANAKE RANGAHAU: SEEDING NEW IDEAS
| PRIORITY THEME | PROJECT TITLE | RESEARCH LEADERS |
| Prevention | Mana-enhancing Research Strategy for Māori Living
with HIV | Milly Stewart, Abby Leota |
| Te Ao Maaori | Ngā Kawenga i Rangiātea | Paaniora Matatahi-Poutapu, Janell Dymus-Kurei |
PEOPLE LEADERSHIP: INVESTING IN PEOPLE
| CATEGORY | PRIORITY THEME | PROJECT TITLE | RESEARCH LEADERS |
| Kia Niwha Leader Fellowship | Therapeutics | Preclinical development of vaccines that rejuvenate the ageing immune system | Dr Theresa Pankhurst |
| Kia Niwha Leader Fellowship | Surveillance | He puna mātauranga rānei te māwhaiwhai? The house of the spider, a spring ofknowledge or not? | Dr Rose Collis |
| Kia Niwha Leader Fellowship | Prevention | Mā te kimi ka kite; Visualising native viruses of Aotearoa whānui | Dr Alice Eruera |
| Kia Niwha Leader Fellowship | Diagnostics, Therapeutics | Mini-lungs to study viral-immune responses | Dr Andrew Highton |
| Kia Niwha Leader Fellowship | Prevention | Applying complexity science to improve outcomes for migrants and refugees duringpandemics | Dr Nadia Charania |
| Kia Niwha Leader Fellowship | Therapeutics | Broad-spectrum antiviral activities within indigenous Pacific traditional medicines | Dr Natalie Netzler |
| PhD Scholarship | Diagnostics | Development of a non-invasive “liquid biopsy” for
Kingella kingae and Staphylococcus aureus infections in children using
cell-free DNA. | Katie Wolf |
| PhD Scholarship | Prevention | A randomised controlled trial of the immunogenicity
and reactogenicity of subcutaneous (SC) vs intramuscular (IM) administration of
COVID-19 vaccination in community pharmacies in Aotearoa New Zealand | Melemafi Porter |
| PhD Scholarship | Surveillance | Measuring and strengthening waning immunity to
measles in fully immunised young adults | Sumanta Saha |
| Masters Scholarship | Diagnostics | Investigating the antiviral range of Rongoā Māori
and traditional Pacific medicines. | Jack Blackwood |
| Masters Scholarship | Prevention | Which HPV vaccination model in Aotearoa New Zealand achieves the highest coverage amongst adolescents? | Sarah Cosgrove |
| Masters Scholarship | Prevention | Epidemiology of Tuberculosis and BCG vaccine
eligibility among Pasifika in Aotearoa New Zealand | Rhonita Schutz |
| Kia Tupu Community Development Grant | Across All | He whakapūaretanga ki te ao mātai rongoā | Te Hao Apaapa-Timu |
Follow Us
General Enquiries
teniwha@otago.ac.nz
Physical Address: 362 Leith Street, Dunedin 9016, New Zealand | Postal: PO Box 56, Dunedin 9054, New Zealand
© Te Niwha Infectious Disease Research Platform 2023. All rights reserved. Co-hosted by ESR and University of Otago.